Therapeutic-area Dossier
Musculoskeletal
Therapeutic-area Dossier for Musculoskeletal (bone, joint and muscle medicines). Australian brands, active ingredients, PBS-listed treatments, PBAC…
- Brand: ADENURIC
- Brand: APO-PIROXICAM
- Brand: ARTHREXIN
- Brand: BRENZYS
- Brand: CELEBREX
- Brand: COLCINE
- Sponsor: Arrotex Pharmaceuticals
- Sponsor: Sandoz
- Sponsor: Alphapharm
- Sponsor: Pharmacor
What is
Musculoskeletal The Musculoskeletal therapeutic area encompasses treatments and products related to bone, joint and muscle health. A total of 112 brands are registered in this area.
Brands registered in
Musculoskeletal The following brands are registered in the Musculoskeletal therapeutic area: — ELADYNOS — Caltrate — ARTHRO-AID — ALENDRONATE-WGR — APO-ALENDRONATE — AURO-ALENDRONATE — FIXTA — FOSAMAX PLUS — MDP — TECHNESCAN
Sponsor landscape
The Musculoskeletal area has 94 active sponsors. Leading sponsors include Arrotex Pharmaceuticals, Carlmark, Zifam Pinnacle, Phytologic Holdings, Ferngrove Pharmaceuticals, RBK Nutraceuticals, Australian Naturalcare Products and Proudex.
PBS and regulatory activity
The latest Pharmaceutical Benefits Scheme Committee (PBAC) outcome in the Musculoskeletal area was recorded on 1 July 2025, with 3 brands holding PBAC outcomes on record. The most recent Australian Public Assessment Report (AusPAR) was published on 6 November 2024, with 1 brand holding an AusPAR on record.